Anticoagulation, atherosclerosis, and heart failure

![Graphic][1] Now all papers published in the European Heart Journal – Cardiovascular Pharmacotherapy are indexed in MEDLINE. This has been done in such a way that papers published in 2015 and during 2016 have also retrospectively been indexed in MEDLINE. The editors are pleased to report that since the journal was approved for MEDLINE indexing by the Literature Selection and Technical Review Committee (LSTRC), the number of submissions to the journal has increased rapidly. The journal will publish short summaries from new ESC guidelines and reports from major meetings. In this issue, Professor Rosano from the UK reports from the Heart Failure Association Congress in Florence, and Professor Perk from Sweden provide a short summary of the new 2016 version of the European Guidelines on Cardiovascular Prevention. In this issue of the journal, Dr Vries and co-workers report data from a study that aimed to explore the level of agreement between windows for different platelet function tests (PFTs) used to classify patients into low, optimal, and high on-treatment platelet reactivity categories in 145 consecutive vulnerable patients. Measurements were performed within 6 months of percutaneous intervention. Patients were considered vulnerable if … stefan.agewall{at}medisin.uio.no [1]: /embed/inline-graphic-1.gif